HCA Healthcare (HCA)
(Delayed Data from NYSE)
$322.86 USD
+0.15 (0.05%)
Updated May 17, 2024 04:00 PM ET
After-Market: $322.73 -0.13 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Brokerage Reports
HCA Healthcare, Inc. [HCA]
Reports for Purchase
Showing records 241 - 260 ( 284 total )
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Initiating Coverage with an OUTPERFORM Rating and $93 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Initiating Coverage with an OUTPERFORM Rating and $93 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Upside Opportunity Offset by Valuation, SCOTUS Risk
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
4Q Admissions Growth Accelerates, but EBITDA Is Mixed
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
The Strong Rebound in Volumes, How Long Will It Continue?
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Ahead on Stronger Volumes, Reform Benefits
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Significantly Higher than Expected 2Q Results
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Proposed FY15 IPPS Rates Slightly Worse than Expected
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Reform Impact Minimal w/1Q Slightly Below; Outlook Reaffirmed
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J